Get startedLog in
    Picture of Infant Bacterial Therapeutics AB logo

    IBT B — Infant Bacterial Therapeutics AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: EMA adopts positive opinion on paediatric investigation plan for IBT's lead product

    Picture of Infant Bacterial Therapeutics AB logoInfant Bacterial Therapeutics AB
    28/09/2017 07:31
    Sept 28 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB (IBT) 
 IBTb.ST  
    * REG-EUROPEAN MEDICINES AGENCY (EMA) ADOPTS A POSITIVE 
OPINION ON THE PAEDIATRIC INVESTIGATION PLAN FOR IBT'S LEAD 
PRODUCT 
    * WE ARE NOW PREPARING FOR PHASE 3 STUDY  - CEO 
 
Source text for Eikon:  ID:nGNE1CYpVN  
Further company coverage:  IBTb.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Infant Bacterial Therapeutics AB

    See all news